Dow Leads in Mixed Session on Amgen Earnings: Stock Market Today
The rest of Wall Street struggled as Advanced Micro Devices earnings caused a chip-stock sell-off.
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
The S&P 500 and the Nasdaq Composite fell for a second straight day as disappointing earnings from mega-cap chipmaker Advanced Micro Devices (AMD) sparked a sell-off across the technology sector. However, the Dow Jones Industrial Average managed to close in positive territory thanks to well-received results from a high-priced health care stock.
After Tuesday's close, AMD said fourth-quarter earnings rose 40% year over year to $1.53 per share, while revenue was up 34% to $10.3 billion. Both figures were higher than Wall Street expected, thanks to a 39% increase in data center revenue.
But Wedbush analyst Matt Bryson says the majority of this data center growth came from MI308 chip sales to China, "suggesting more muted growth for AI silicon net this one-time benefit." He adds that the sales of these chips also gave a moderate lift to the company's Q1 guidance.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
And while Bryson believes AMD's outlook is strong even without the benefit of these chip sales to China, the company's inability "to extract incremental value" from "growing shortages of CPUs" likely sparked today's post-earnings slide.
AMD ended the day down 17.3%, while many of its fellow semiconductor stocks, including Broadcom (AVGO, -3.8%) and Micron Technology (MU, -9.6%), finished lower as well.
Amgen keeps the Dow above water
These sharp losses caused the tech-heavy Nasdaq to close down 1.5% at 22,904 and the broader S&P 500 to fall 0.5% to 6,882. But the blue-chip Dow added 0.5% to 49,501 after Amgen (AMGN) rallied 8.2% on its better-than-expected Q4 print.
The drugmaker also gave upbeat guidance that William Blair analyst Matt Phipps says "highlights the strong growth" for "key brands such as Repatha, Tezspire, Uplizna, Evenity, and Imdelltra."
Looking for more timely stock market news to help gauge the health of your portfolio? Sign up for Closing Bell, our free newsletter that's delivered straight to your inbox at the close of each trading day.
At $366 per share, AMGN is one of the higher-priced members of the 30-stock index. And this helped the price-weighted Dow to a positive close today despite sell-offs in Goldman Sachs (GS, -2.7%), Nvidia (NVDA, -3.4%) and UnitedHealth Group (UNH, -2.9%).
Brookfield pops on dividend hike, new CEO; Enphase soars 39%
Elsewhere on the earnings calendar, Brookfield Asset Management (BAM) jumped 4.9% after the alternative asset management firm reported higher-than-expected Q4 earnings. It also hiked its dividend by 15% and named Connor Teskey as its new CEO.
CFRA Research analysts maintained a Buy rating on the financial stock after earnings. "Looking ahead, BAM is well positioned to capitalize on trends in AI-related infrastructure and renewable energy," including electricity and power, CFRA writes.
Enphase Energy (ENPH), meanwhile, soared 38.6% after the solar and battery supplier reported a fourth-quarter beat. The company also gave strong Q1 guidance.
"Demand in the U.S. reached its highest levels in more than 2 years in Q4, driven partially by a pull-forward in demand before" residential clean energy credits expired on December 31, say Susquehanna analysts Charles Minervino and Eric Clay. "Q1 is expected to mark a low point for shipments, before improving in the second-half as utility rates see upward pressure and prepaid leases gain greater adoption."
The analysts have a Neutral (Hold) rating on ENPH, which is technically a tech stock, and a price target of $46 – a roughly 10% discount to current levels.
Private payrolls come up short
Over on the economic calendar, data from ADP showed the U.S. added 22,000 private payrolls in January, well below the 45,000 economists expected.
"The strongest sector was, once again, the education and health services sector, while the weakest was the professional and business services sector," write Raymond James economists Eugenio Alemán, Ph.D., and Giampiero Fuentes.
The economists add that the ADP data could signal a weak January jobs report, which will be released next Wednesday, February 11, after being delayed due to the now-ended government shutdown.
Related content
- Best Stocks to Buy Now
- The Kiplinger 25: Our Favorite No-Load Mutual Funds
- Best Dividend Kings for Decades of Dividend Growth
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.

With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at a local investment research firm. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
4 High-End Experiences Worth the Splurge After 50These curated date ideas provide the perfect backdrop for couples ready to enjoy the very best that the world has to offer.
-
Health Care Stocks Have Sagged. Can You Bet on a Recovery?The flagging health care sector has perked up a bit lately. Is it time to invest?
-
Costco's Auto Program: Can Membership Pricing Really Save You Money on a Car?Costco's Auto Program can simplify the car-buying process with prearranged pricing and member perks. Here's what to know before you use it.
-
Health Care Stocks Have Sagged. Can You Bet on a Recovery?The flagging health care sector has perked up a bit lately. Is it time to invest?
-
Your Retirement Age Is Just a Number: Today's Retirement Goal Is 'Work Optional'Becoming "work optional" is about control — of your time, your choices and your future. This seven-step guide from a financial planner can help you get there.
-
Have You Fallen Into the High-Earning Trap? This Is How to EscapeHigh income is a gift, but it can pull you into higher spending, undisciplined investing and overreliance on future earnings. These actionable steps will help you escape the trap.
-
I'm a Financial Adviser: These 3 Questions Can Help You Navigate a Noisy Year With Financial ClarityThe key is to resist focusing only on the markets. Instead, when making financial decisions, think about your values and what matters the most to you.
-
Dow Absorbs Disruptions, Adds 370 Points: Stock Market TodayInvestors, traders and speculators will hear from President Donald Trump tonight, and then they'll listen to Nvidia CEO Jensen Huang tomorrow.
-
Private Capital Wants In on Your Retirement AccountDoes offering private capital in 401(k)s represent an exciting new investment opportunity for "the little guy," or an opaque and expensive Wall Street product?
-
It's Time to Bust These 3 Long-Term Care Myths (and Face Some Uncomfortable Truths)None of us wants to think we'll need long-term care when we get older, but the odds are roughly even that we will. Which is all the more reason to understand the realities of LTC and how to pay for it.
-
Fix Your Mix: How to Derisk Your Portfolio Before RetirementIn the run-up to retirement, your asset allocation needs to match your risk tolerance without eliminating potential for growth. Here's how to find the right mix.